Transcriptional and Post-Translational Control Mechanisms for EphB4 Expression in Physiology and Cancer Disease.


Journal

Critical reviews in eukaryotic gene expression
ISSN: 1045-4403
Titre abrégé: Crit Rev Eukaryot Gene Expr
Pays: United States
ID NLM: 9007261

Informations de publication

Date de publication:
2021
Historique:
entrez: 4 8 2021
pubmed: 5 8 2021
medline: 17 2 2022
Statut: ppublish

Résumé

EphB4 is a membrane tyrosine kinase receptor involved in a number of physiologic and pathologic conditions, cancer being the one drawing the highest attention. In mammalians, EphB4 regulates blood vessel growth and differentiation. EphB4 also mediates a number of cancer promoting effects including angiogenesis, invasion, and metastasis. Its effects have been linked to both EphrinB2-dependent and to EphrinB2-independent mechanisms. In spite of its emerging role in physiology and disease, the regulation of EphB4 cellular expression has been poorly described until recently. The present mini-review summarizes the latest findings on EphB4 regulation at the transcriptional and post-transcriptional level and discusses the biologic implications of such novel findings. Perspective on the scenarios opened by such findings and the open questions in EphB4 research is also provided.

Identifiants

pubmed: 34347982
pii: 3b40abcc31226ddb,501dc37f7f1bf0d9
doi: 10.1615/CritRevEukaryotGeneExpr.2021037928
doi:

Substances chimiques

Insulin-Like Growth Factor II 67763-97-7
Receptor, EphB4 EC 2.7.10.1
Receptor, Insulin EC 2.7.10.1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

83-88

Auteurs

Pierluigi Scalia (P)

Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, USA 19122; The ISOPROG-Somatolink EPFP Research Network, Philadelphia, USA 19102 and Caltanissetta, Italy 93100.

JeanMarc Maurancy (J)

Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, USA 19122.

Antonio Giordano (A)

Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA; Department of Medical Biotechnologies, University of Siena, Siena, 53100, Italy.

Stephen J Williams (SJ)

Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, USA 19122; The ISOPROG-Somatolink EPFP Research Network, Philadelphia, USA 19102 and Caltanissetta, Italy 93100.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH